This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
CSL Behring GmbH
CSL Behring GmbH, a leading global biotechnology company, is headquartered in Austria (AT) and operates extensively across Europe, North America, and Asia. Founded in 1904, CSL Behring has established itself as a pioneer in the development of innovative therapies for rare and serious medical conditions, particularly in the fields of immunology, haematology, and respiratory health. The company is renowned for its high-quality plasma-derived therapies, including immunoglobulins and clotting factor concentrates, which are essential for patients with immune deficiencies and bleeding disorders. CSL Behring's commitment to research and development has positioned it as a market leader, with notable achievements in advancing treatment options and improving patient outcomes. With a strong focus on patient care and scientific excellence, CSL Behring continues to make significant contributions to the biopharmaceutical industry.
DitchCarbon Score
How does CSL Behring GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CSL Behring GmbH's score of 49 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CSL Behring GmbH, headquartered in Austria (AT), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of CSL Limited, which may influence its climate commitments and reporting practices. CSL Limited, the parent organisation, has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for CSL Behring GmbH have not been disclosed. As a subsidiary, CSL Behring GmbH's climate commitments may align with those of CSL Limited, which is focused on reducing its carbon footprint and enhancing sustainability practices across its operations. The absence of direct emissions data suggests that CSL Behring GmbH is still in the process of developing its own specific climate strategies or reporting frameworks. In summary, while CSL Behring GmbH does not currently provide emissions data or specific reduction targets, it is part of a corporate family that is actively engaged in climate initiatives through its parent company, CSL Limited.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CSL Behring GmbH is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
